FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324336301> ?p ?o ?g. }

• W4324336301 abstract "To report sex specific overall attendance rate, prevalence of screen detected cardiovascular conditions, proportion of unknown conditions before screening, and proportion initiating prophylactic medicine among 67 year olds in Denmark.Cross sectional cohort study.Since 2014, all 67 year olds in Viborg, Denmark, have been invited to screening for abdominal aortic aneurysm (AAA), peripheral arterial disease (PAD), carotid plaque (CP), hypertension, cardiac disease, and type 2 diabetes. Individuals with AAA, PAD, and or CP are recommended cardiovascular prophylaxis. Combining data with registries has facilitated estimation of unknown screen detected conditions. Up to August 2019, 5 505 had been invited; registry data were available for the first 4 826 who were invited.The attendance rate was 83.7%, without sex difference. Screen detected prevalence was significantly lower among women than men: AAA, 5 (0.3%) vs. 38 (1.9%) (p < .001); PAD, 90 (4.5%) vs. 134 (6.6%) (p = .011); CP, 641 (31.8%) vs. 907 (44.8%) (p < .001); arrhythmia, 26 (1.4%) vs. 77 (4.2%) (p < .001); blood pressure ≥ 160/100 mmHg, 277 (13.8%) vs. 346 (17.1%) (p = .004); and HbA1c ≥ 48 mmol/mol, 155 (7.7%) vs. 198 (9.8%) (p = .019), respectively. Pre-screening proportions of unknown conditions were particularly high for AAA (95.4%) and PAD (87.5%). AAA, PAD, and or CP were found in 1 623 (40.2%), of whom 470 (29.0%) received pre-screening antiplatelets and 743 (45.8%) lipid lowering therapy. Furthermore, 413 (25.5%) started antiplatelet therapy and 347 (21.4%) started lipid lowering therapy. Only smoking was significantly associated with all vascular conditions in multivariable analysis: odds ratios (ORs) for current smoking were AAA 8.11 (95% CI 2.27 - 28.97), PAD 5.60 (95% CI 3.61 - 8.67) and CP 3.64 (95% CI 2.95 - 4.47).The attendance rate signals public acceptability for attending cardiovascular screening. Men had more screen detected conditions than women, but prophylactic medicine was started equally frequently in both sexes. Sex specific cost effectiveness follow up is warranted." @default.
• W4324336301 created "2023-03-16" @default.
• W4324336301 creator A5004057234 @default.
• W4324336301 creator A5011622426 @default.
• W4324336301 creator A5013499380 @default.
• W4324336301 creator A5041382502 @default.
• W4324336301 creator A5050067048 @default.
• W4324336301 creator A5078775322 @default.
• W4324336301 creator A5087872806 @default.
• W4324336301 creator A5087873723 @default.
• W4324336301 date "2023-03-01" @default.
• W4324336301 modified "2023-09-30" @default.
• W4324336301 title "Relevance of the Viborg Population-Based Screening Programme (VISP) for Cardiovascular Conditions Among 67-Year-Olds: Attendance Rate, Prevalence, and Proportion of Initiated Cardiovascular Medicine Stratified By Sex" @default.
• W4324336301 cites W1503915976 @default.
• W4324336301 cites W1604038557 @default.
• W4324336301 cites W1930457864 @default.
• W4324336301 cites W1978670003 @default.
• W4324336301 cites W2050751456 @default.
• W4324336301 cites W2107165713 @default.
• W4324336301 cites W2109344018 @default.
• W4324336301 cites W2148092884 @default.
• W4324336301 cites W2155311570 @default.
• W4324336301 cites W2165631963 @default.
• W4324336301 cites W2468188540 @default.
• W4324336301 cites W2551469077 @default.
• W4324336301 cites W2587371977 @default.
• W4324336301 cites W2745813324 @default.
• W4324336301 cites W2747346121 @default.
• W4324336301 cites W2787169205 @default.
• W4324336301 cites W2791215514 @default.
• W4324336301 cites W2796221147 @default.
• W4324336301 cites W2801198774 @default.
• W4324336301 cites W2883565024 @default.
• W4324336301 cites W2898896627 @default.
• W4324336301 cites W2927914951 @default.
• W4324336301 cites W2949771329 @default.
• W4324336301 cites W2950769483 @default.
• W4324336301 cites W2953618807 @default.
• W4324336301 cites W2995889897 @default.
• W4324336301 cites W3002421644 @default.
• W4324336301 cites W3005558203 @default.
• W4324336301 cites W3019335011 @default.
• W4324336301 cites W3089164638 @default.
• W4324336301 cites W3113178943 @default.
• W4324336301 cites W3123358732 @default.
• W4324336301 cites W3156570849 @default.
• W4324336301 cites W3183402545 @default.
• W4324336301 cites W3187451579 @default.
• W4324336301 cites W3194478644 @default.
• W4324336301 cites W4206651380 @default.
• W4324336301 cites W4322719898 @default.
• W4324336301 doi "https://doi.org/10.1016/j.ejvs.2023.03.014" @default.
• W4324336301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36931553" @default.
• W4324336301 hasPublicationYear "2023" @default.
• W4324336301 type Work @default.
• W4324336301 citedByCount "0" @default.
• W4324336301 crossrefType "journal-article" @default.
• W4324336301 hasAuthorship W4324336301A5004057234 @default.
• W4324336301 hasAuthorship W4324336301A5011622426 @default.
• W4324336301 hasAuthorship W4324336301A5013499380 @default.
• W4324336301 hasAuthorship W4324336301A5041382502 @default.
• W4324336301 hasAuthorship W4324336301A5050067048 @default.
• W4324336301 hasAuthorship W4324336301A5078775322 @default.
• W4324336301 hasAuthorship W4324336301A5087872806 @default.
• W4324336301 hasAuthorship W4324336301A5087873723 @default.
• W4324336301 hasConcept C126322002 @default.
• W4324336301 hasConcept C134018914 @default.
• W4324336301 hasConcept C162324750 @default.
• W4324336301 hasConcept C164705383 @default.
• W4324336301 hasConcept C2777180221 @default.
• W4324336301 hasConcept C2778173179 @default.
• W4324336301 hasConcept C2779134260 @default.
• W4324336301 hasConcept C2908647359 @default.
• W4324336301 hasConcept C50522688 @default.
• W4324336301 hasConcept C555293320 @default.
• W4324336301 hasConcept C71924100 @default.
• W4324336301 hasConcept C72563966 @default.
• W4324336301 hasConcept C84393581 @default.
• W4324336301 hasConcept C99454951 @default.
• W4324336301 hasConceptScore W4324336301C126322002 @default.
• W4324336301 hasConceptScore W4324336301C134018914 @default.
• W4324336301 hasConceptScore W4324336301C162324750 @default.
• W4324336301 hasConceptScore W4324336301C164705383 @default.
• W4324336301 hasConceptScore W4324336301C2777180221 @default.
• W4324336301 hasConceptScore W4324336301C2778173179 @default.
• W4324336301 hasConceptScore W4324336301C2779134260 @default.
• W4324336301 hasConceptScore W4324336301C2908647359 @default.
• W4324336301 hasConceptScore W4324336301C50522688 @default.
• W4324336301 hasConceptScore W4324336301C555293320 @default.
• W4324336301 hasConceptScore W4324336301C71924100 @default.
• W4324336301 hasConceptScore W4324336301C72563966 @default.
• W4324336301 hasConceptScore W4324336301C84393581 @default.
• W4324336301 hasConceptScore W4324336301C99454951 @default.
• W4324336301 hasLocation W43243363011 @default.
• W4324336301 hasLocation W43243363012 @default.
• W4324336301 hasOpenAccess W4324336301 @default.
• W4324336301 hasPrimaryLocation W43243363011 @default.
• W4324336301 hasRelatedWork W1563850031 @default.
• W4324336301 hasRelatedWork W2045367862 @default.
• W4324336301 hasRelatedWork W2074686124 @default.

• next